(Q53627522)
Statements
Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial. (English)
1 reference
Champlin R
1 reference
Deisseroth AB
1 reference
Holmes F
1 reference
Hortobagyi G
1 reference
1 February 1996
1 reference
7
1 reference
3
1 reference
401-416
1 reference
Identifiers
1 reference